In line with the previous reports [49,50], our findings demonstrated that HCC progression to be associated with increased hepatic inflammation with concomitant up-regulation of hepatic expression of IL-1β, TNF-α, and NF-κB. This evidence concerns the gene IL1B and hepatocellular carcinoma.